| Completed | Study of BB-025, Alone and After BB-031, in Healthy Volunteers NCT07202663 | Basking Biosciences, Inc. | Phase 1 |
| Not Yet Recruiting | Single Ascending Dose and Multiple Ascending Dose Study of AVR-48 NCT06847698 | AyuVis Research, Inc. | Phase 1 |
| Completed | Reevaluation Prediction of the Effect Site Propofol Eleveld Model Using Slow and Fast Induction NCT07237477 | Pablo O. Sepulveda | — |
| Recruiting | KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts NCT06469450 | Mikko Niemi | Phase 1 |
| Completed | Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR NCT06725992 | Il-Yang Pharm. Co., Ltd. | Phase 1 |
| Completed | Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience NCT06072170 | Altasciences Company Inc. | Phase 1 |
| Completed | SB17170 Phase1 Trial in Healthy Volunteer NCT05795192 | SPARK Biopharma | Phase 1 |
| Completed | Electrophysiological Effects of Potential QT Prolonging Drugs NCT05716854 | Food and Drug Administration (FDA) | Phase 1 |
| Not Yet Recruiting | Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study NCT05764356 | Peking University First Hospital | — |
| Completed | Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-A NCT05539872 | Amphastar Pharmaceuticals, Inc. | Phase 2 / Phase 3 |
| Unknown | Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs G NCT05652595 | Geropharm | Phase 1 |
| Completed | Clinical Decision Support Tool for Vancomycin Dosing in Children NCT04911270 | University of Maryland, Baltimore | N/A |
| Completed | Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Vo NCT05153837 | Centre Hospitalier Universitaire, Amiens | N/A |
| Completed | Study of DTRI-031 in Healthy Volunteers NCT05005520 | Basking Biosciences, Inc. | Phase 1 |
| Completed | Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products NCT04183491 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists NCT04183192 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors NCT04189484 | Food and Drug Administration (FDA) | Phase 1 |
| Unknown | Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutro NCT04250038 | Universitaire Ziekenhuizen KU Leuven | — |
| Unknown | Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade NCT04131218 | Guangzhou General Hospital of Guangzhou Military Command | Phase 4 |
| Completed | Modeling and Application of Triple Drug Response Surface Models NCT03813875 | Taipei Veterans General Hospital, Taiwan | — |
| Completed | A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers NCT04100759 | Ain Shams University | Phase 1 / Phase 2 |
| Completed | The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflo NCT03895229 | Ain Shams University | Phase 1 |
| Unknown | A Phase 1 Study of Tegoprazan on Healthy Male Volunteers NCT03530228 | HK inno.N Corporation | Phase 1 |
| Completed | A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers NCT03378284 | HK inno.N Corporation | Phase 1 |
| Unknown | Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric NCT03337581 | Chinese Medical Association | Phase 4 |
| Unknown | Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants NCT03161496 | Cui Yimin | — |
| Unknown | Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor NCT03161002 | Cui Yimin | — |
| Completed | CiPA Phase 1 ECG Biomarker Validation Study NCT03070470 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD NCT02512575 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects NCT02532998 | AstraZeneca | Phase 1 |
| Completed | PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants NCT02306915 | Merckle GmbH | Phase 1 |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese P NCT02209506 | Takeda | Phase 1 |
| Completed | Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block NCT02308748 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | Clopidogrel And Ticagrelor in Healthy Subjects NCT02086903 | Dong-A University | Phase 3 |
| Completed | A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive NCT02085863 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 1 |
| Completed | Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products NCT02010632 | Khon Kaen University | Phase 1 |
| Completed | Eplerenone and Extracellular Adenosine Formation NCT01837108 | Radboud University Medical Center | Phase 4 |
| Completed | Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. NCT01692262 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subject NCT01815684 | Astellas Pharma Europe B.V. | Phase 1 |
| Completed | A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed NCT01958047 | Astellas Pharma Europe B.V. | Phase 1 |
| Completed | Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of NCT01954589 | Idorsia Pharmaceuticals Ltd. | Phase 1 |
| Completed | Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Sc NCT01226316 | AstraZeneca | Phase 1 |
| Withdrawn | A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism an NCT01214122 | AstraZeneca | Phase 1 |
| Completed | Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study NCT01158755 | Universitas Padjadjaran | Phase 2 |
| Completed | Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol NCT01214941 | Turku University Hospital | Phase 4 |
| Unknown | Pharmacodynamics Aspects Of Porcine Heparin Sodium, Produced by Eurofarma, Compared Heparin Sodium, Produced b NCT01034488 | Azidus Brasil | Phase 2 / Phase 3 |
| Completed | Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleo NCT00810303 | University Medicine Greifswald | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K NCT01364974 | Astellas Pharma Inc | Phase 1 |
| Completed | Pharmacodynamic Characterization of Dienogest NCT00754871 | Bayer | Phase 1 |
| Completed | Propofol in Obese Children NCT01242241 | Baylor College of Medicine | Phase 3 |
| Completed | A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Sub NCT01655056 | Astellas Pharma Europe B.V. | Phase 1 |
| Completed | Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety NCT01820143 | Il-Yang Pharm. Co., Ltd. | Phase 1 |